Sun Yat-sen University, Guangzhou, China.
Arch Biochem Biophys. 2010 Oct 15;502(2):112-20. doi: 10.1016/j.abb.2010.07.012. Epub 2010 Jul 18.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. This article shows significant data duplication and overlap with Liu, Weihua, et al., Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. European Journal of Pharmacology. 2010 Jul 25;638(1-3):150-5 (https://doi.org/10.1016/j.ejphar.2010.04.033) without adequate referencing. Although there is a slight difference in the methodology section regarding alloxan-induced diabetes models in the two articles, there is a clear overlap between Table 2 of Lan, Tian, et al., (2010); and Tables 1 and 2 of Liu, Weihua, et al. (2010). The two manuscripts were submitted from the same laboratory in the same year.
请参阅 Elsevier 关于文章撤回的政策 (https://www.elsevier.com/locate/withdrawalpolicy)。应主编要求,本文已被撤回。本文与 Liu, Weihua 等人的研究存在显著的数据重复和重叠,Liu, Weihua 等人的研究题为“Berberine 对糖尿病肾病小鼠基质积累和 NF-kappa B 信号通路的影响”,发表于《欧洲药理学杂志》。2010 年 7 月 25 日;638(1-3):150-5(https://doi.org/10.1016/j.ejphar.2010.04.033),未充分引用。尽管两篇文章的方法部分在关于用四氧嘧啶诱导的糖尿病模型方面略有不同,但 Lan, Tian 等人的表 2 (2010 年);与 Liu, Weihua 等人的表 1 和表 2 之间存在明显的重叠。两篇论文都来自同年同一实验室。